{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T19:59:38.635745+00:00","published_at":"2026-10-19T14:47:33.80064+00:00","section":"evidence","data":{"state":"PUBLISHED","evidence":[{"evidence_id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","aliases":[],"source_type":"canonical_identity","source_family":"open_web","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","title":"Alpha canonical company public projection","identifier":null,"locator":null,"source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"open_web","score":35,"source_family":"open_web","reasons":["Matched open_web source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:legal_name:1","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:entity_status:3","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:published_fact:4","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:security_listing:24","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:security_listing:25","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:legal_name:1","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:entity_status:3","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:published_fact:4","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:security_listing:24","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:security_listing:25"]},{"evidence_id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","aliases":[],"source_type":"sec_proxy","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","identifier":null,"locator":null,"source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:5","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:6","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:7","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:8","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:9","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:10","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:11","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:12","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:13","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:14","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:15","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:16","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:17","stance":"supports"},{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:18","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:5","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:6","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:7","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:8","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:9","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:10","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:11","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:12","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:13","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:14","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:15","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:16","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:17","alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:18"]},{"evidence_id":"alpha:projection-evidence:document:5c7c31a591e4d31718896c968aed1e47b17b568721ba105806162b5781e1f055","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","title":"SABS 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:17.063816+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:19","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:19"]},{"evidence_id":"alpha:projection-evidence:document:1cea6fb8e8c6ccc94b80f65ac54b294df065b6da99a4762a42a7e19327df2a80","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","title":"SABS 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:16.623978+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:20","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:20"]},{"evidence_id":"alpha:projection-evidence:document:27fbc7f2b3b35398e497d0e0609f5002002b5aecce0754b199770545a21b1a22","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","title":"SABS 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:15.809833+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:21","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:21"]},{"evidence_id":"alpha:projection-evidence:document:f0f6f017d542cca9dea27016a7d46a868e13b7b2917c77f4cdeb9958a605ca84","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","title":"SABS 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:16.167724+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:22","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:22"]},{"evidence_id":"alpha:projection-evidence:document:0d347265c69b9a431f4740aeaf9fc5105b5fda40de65ab61595bb57a555772b0","aliases":[],"source_type":"sec_filing","source_family":"sec","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","title":"SABS 10-K executive officers","identifier":null,"locator":null,"source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:15.446113+00:00","content_hash":null,"authority":{"policy_version":"alpha-source-authority-v1","tier":"authoritative","score":100,"source_family":"sec","reasons":["Matched sec source policy."]},"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"},"stance":[{"claim_id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:23","stance":"supports"}],"claim_ids":["alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:23"]}]},"claims":[{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:legal_name:1","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"schema:legalName","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"SAB Biotherapeutics, Inc.","claim_type":"legal_name","predicate_id":"alpha:predicate:legal_name","predicate_version":1,"machine_key":"legal_name","human_label":"Legal Name","governed_predicate":true,"machine_value":"SAB Biotherapeutics, Inc.","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:entity_status:3","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:entityStatus","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Public listing published","claim_type":"entity_status","predicate_id":"alpha:predicate:entity_status","predicate_version":1,"machine_key":"entity_status","human_label":"Entity Status","governed_predicate":true,"machine_value":"Public listing published","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:published_fact:4","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:country","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"US","claim_type":"published_fact","predicate_id":"alpha:predicate:published_fact","predicate_version":1,"machine_key":"published_fact","human_label":"Published Fact","governed_predicate":true,"machine_value":"US","corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:5","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alexandra-kropotova","object_label":"Alexandra Kropotova","object_source_name_forms":[],"value":"Alexandra Kropotova: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alexandra-kropotova","name":"Alexandra Kropotova"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:6","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andrew-moin","object_label":"Andrew Moin","object_source_name_forms":[],"value":"Andrew Moin: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andrew-moin","name":"Andrew Moin"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:7","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christine-hamilton","object_label":"Christine Hamilton","object_source_name_forms":[],"value":"Christine Hamilton: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christine-hamilton","name":"Christine Hamilton"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:8","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christoph-bausch","object_label":"Christoph Bausch","object_source_name_forms":[],"value":"Christoph Bausch: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christoph-bausch","name":"Christoph Bausch"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:9","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-link-mba","object_label":"David Link, MBA","object_source_name_forms":[],"value":"David Link, MBA: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-link-mba","name":"David Link, MBA"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:10","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:eddie-j-sullivan-phd","object_label":"Eddie J. Sullivan, PhD","object_source_name_forms":[],"value":"Eddie J. Sullivan, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:eddie-j-sullivan-phd","name":"Eddie J. Sullivan, PhD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:11","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:erick-lucera","object_label":"Erick Lucera","object_source_name_forms":[],"value":"Erick Lucera: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:erick-lucera","name":"Erick Lucera"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:12","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jay-s-skyler-md","object_label":"Jay S. Skyler, MD","object_source_name_forms":[],"value":"Jay S. Skyler, MD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jay-s-skyler-md","name":"Jay S. Skyler, MD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:13","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jeffrey-g-spragens","object_label":"Jeffrey G. Spragens","object_source_name_forms":[],"value":"Jeffrey G. Spragens: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jeffrey-g-spragens","name":"Jeffrey G. Spragens"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:14","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:katie-ellias","object_label":"Katie Ellias","object_source_name_forms":[],"value":"Katie Ellias: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:katie-ellias","name":"Katie Ellias"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:15","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lucy-to","object_label":"Lucy To","object_source_name_forms":[],"value":"Lucy To: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lucy-to","name":"Lucy To"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:16","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:samuel-j-reich","object_label":"Samuel J. Reich","object_source_name_forms":[],"value":"Samuel J. Reich: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:samuel-j-reich","name":"Samuel J. Reich"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:17","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:scott-giberson","object_label":"Scott Giberson","object_source_name_forms":[],"value":"Scott Giberson: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:scott-giberson","name":"Scott Giberson"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:18","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:william-polvino-md","object_label":"William Polvino, MD","object_source_name_forms":[],"value":"William Polvino, MD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:william-polvino-md","name":"William Polvino, MD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:19","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alexandra-kropotova-md","object_label":"Alexandra Kropotova, MD","object_source_name_forms":[],"value":"Alexandra Kropotova, MD: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alexandra-kropotova-md","name":"Alexandra Kropotova, MD"},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:5c7c31a591e4d31718896c968aed1e47b17b568721ba105806162b5781e1f055","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:17.063816+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:20","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christoph-bausch-phd","object_label":"Christoph Bausch, PhD","object_source_name_forms":[],"value":"Christoph Bausch, PhD: Chief Operating Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christoph-bausch-phd","name":"Christoph Bausch, PhD"},"title":"Chief Operating Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:1cea6fb8e8c6ccc94b80f65ac54b294df065b6da99a4762a42a7e19327df2a80","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:16.623978+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:21","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:eddie-j-sullivan-phd","object_label":"Eddie J. Sullivan, PhD","object_source_name_forms":[],"value":"Eddie J. Sullivan, PhD: President","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:eddie-j-sullivan-phd","name":"Eddie J. Sullivan, PhD"},"title":"President","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:27fbc7f2b3b35398e497d0e0609f5002002b5aecce0754b199770545a21b1a22","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:15.809833+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:22","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:lucy-to","object_label":"Lucy To","object_source_name_forms":[],"value":"Lucy To: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:lucy-to","name":"Lucy To"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:f0f6f017d542cca9dea27016a7d46a868e13b7b2917c77f4cdeb9958a605ca84","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:16.167724+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:leadership_role:23","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:samuel-j-reich","object_label":"Samuel J. Reich","object_source_name_forms":[],"value":"Samuel J. Reich: Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:samuel-j-reich","name":"Samuel J. Reich"},"title":"Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-09","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-09","valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:document:0d347265c69b9a431f4740aeaf9fc5105b5fda40de65ab61595bb57a555772b0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:15.446113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-09T00:00:00+00:00","effective_from":"2026-03-09","effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:security_listing:24","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"SABS (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"SABS","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2:security_listing:25","subject_id":"alpha:company:ddd83fd3-1f97-457e-9f86-71ca76e7e2c2","predicate":"alpha:hasSecurityListing","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"SABSW (NASDAQ)","claim_type":"security_listing","predicate_id":"alpha:predicate:security_listing","predicate_version":1,"machine_key":"security_listing","human_label":"Security Listing","governed_predicate":true,"machine_value":{"kind":"security_listing","ticker":"SABSW","exchange":"NASDAQ","exchange_display":"NASDAQ","mic":"XNAS","currency":"Unavailable","security_type":"equity","listing_status":"active","is_primary":true},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:47:33.80064+00:00","sources":[{"id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:a087cdf5d6bb3c00d6f7fe38c9c7d2caa3361c021f3c97dbcfc65c94a884cc55","identity_scope":"representation_reference","source_type":"canonical_identity","title":"Alpha canonical company public projection","publisher":"Alpha canonical company public projection","url":"https://www.alpha.ac/api/public/companies/sab-biotherapeutics-inc","source_date":null,"retrieved_at":"2026-10-19T14:47:33.80064+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:bb8575256729b9236df64895b17d987c265cdc1fc6f57704199f089c776a55d0","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"SAB Biotherapeutics, Inc. DEF 14A 2025-08-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312525192856/sabs_def14a_series_b_xxb.htm","source_date":"2025-08-29","retrieved_at":"2026-04-28T22:50:08.147+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5c7c31a591e4d31718896c968aed1e47b17b568721ba105806162b5781e1f055","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:17.063816+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:1cea6fb8e8c6ccc94b80f65ac54b294df065b6da99a4762a42a7e19327df2a80","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:16.623978+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:27fbc7f2b3b35398e497d0e0609f5002002b5aecce0754b199770545a21b1a22","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:15.809833+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f0f6f017d542cca9dea27016a7d46a868e13b7b2917c77f4cdeb9958a605ca84","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:16.167724+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0d347265c69b9a431f4740aeaf9fc5105b5fda40de65ab61595bb57a555772b0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SABS 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000183321426000003/sabs-20251231.htm","source_date":"2026-03-09T00:00:00+00:00","retrieved_at":"2026-05-16T07:53:15.446113+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.818,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.865,"cross_source_agreement":0.75,"temporal_completeness":0.263},"diagnostics":{"published_claims":24,"factual_claims":24,"claims_with_linked_evidence":24,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":19,"temporal_claims_with_valid_from":5,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-19T14:47:33.80064+00:00","observed_at":"2026-10-19T14:47:33.80064+00:00","reviewed_at":"2026-10-19T14:47:33.80064+00:00","verified_at":"2026-10-19T14:47:33.80064+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":24,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/sab-biotherapeutics-inc/evidence","section":"evidence","href":"https://registry.alpha.ac/api/public/companies/sab-biotherapeutics-inc?format=record&section=evidence","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}